Clinical Trials on Inflammatory Bowel Diseases in Belgium

Total 11159 results

KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Mucosal Gene Expression Defects in IBD

Inflammatory Bowel Diseases

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases (MODIFI)

Inflammatory Bowel Diseases

Belgium
KU Leuven

Completed

Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Inflammatory Bowel Diseases

Belgium
University of Liege

Completed

Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease (ACHILLE)

Inflammatory Bowel Diseases | Exercise Therapy

Belgium
Pieter Dewint, MD PhD

Completed

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders (SafE-OrBi)

Inflammatory Bowel Diseases

Belgium
Arena Pharmaceuticals

Terminated

Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations

Inflammatory Bowel Diseases | Skin Extra-intestinal Manifestations

Belgium, Germany, Serbia
Universitaire Ziekenhuizen KU Leuven

Recruiting

COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study (OATS)

Inflammatory Bowel Diseases | Crohn Disease | Diet, Healthy

Belgium
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Takeda

Active, not recruiting

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Inflammatory Bowel Diseases | Colitis, Ulcerative | Crohns Disease

Belgium
University Medical Center Groningen
Bühlmann Laboratories AG; European Crohn´s and Colitis Organisation

Enrolling by invitation

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease (FREE)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Belgium, Netherlands, Spain
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Effects of a Mindfulness Based Intervention on IBD Disability (EMBODY)

Crohn Disease

Belgium
KU Leuven

Completed

Prebiotic Effect on Metabolites in Crohn's Disease

Crohn Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Recruiting

An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE)

Crohn Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Active, not recruiting

Loss of RESponse to Ustekinumab Treated by Dose Escalation (REScUE)

Crohn Disease

Belgium
Abivax S.A.

Unknown

Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease

Belgium
Tillotts Pharma AG

Completed

EPANOVA in Crohn's Disease, Study 1 (EPIC-1)

Crohn's Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Schering-Plough; Centocor BV

Completed

Top Down Versus Step Up Strategies in Crohn's Disease

Crohn's Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

Crohn's Disease

Belgium
GlaxoSmithKline

Completed

PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease

Crohn's Disease

Netherlands, Belgium
Belgian Inflammatory Bowel Disease Research and...
Celltrion

Active, not recruiting

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization (AMARETTO)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Belgium
University of Liege
Centre Hospitalier Universitaire de Liege

Recruiting

MSC Intratissular Injection in Crohn Disease Patients (MSC)

Efficacy and Safety

Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Completed

Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)

CD

Belgium, France
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
University of Liege

Terminated

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

Crohn's Disease

Belgium
Fast Forward Pharmaceuticals

Unknown

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Crohn's Disease

Belgium, Netherlands
Exeliom Biosciences
Alimentiv Inc.

Recruiting

EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease (MAINTAIN)

Crohn Disease

Poland, Belgium
Centre Hospitalier Universitaire de Liege

Recruiting

Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?

Efficacy | Safety Issues

Belgium
Universitaire Ziekenhuizen KU Leuven
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Unknown

Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny (HELP-AID)

Crohn Disease | Colitis, Ulcerative

Belgium
Italfarmaco

Terminated

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease (CD)

Crohn's Disease

Belgium, Italy, Netherlands
University Medical Center Groningen
Cisbio Bioassays

Completed

Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD (CACATU)

Irritable Bowel Syndrome | Abdominal Pain | Diarrhea | Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease | Rectal Bloodloss

Netherlands, Belgium
Shire

Completed

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Colitis, Ulcerative

Belgium
Boehringer Ingelheim

Terminated

A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials

Crohn Disease

Belgium, Germany, Austria, Netherlands, Korea, Republic of
University Hospital, Ghent
Abbott

Completed

Switching From Adalimumab to Infliximab (ADA-IFX)

Crohn's Disease

Belgium
Erasmus Medical Center
Hospira, now a wholly owned subsidiary of Pfizer; ZonMw: The Netherlands Organisation...

Completed

Top-down Infliximab Study in Kids With Crohn's Disease (TISKids)

Crohn's Disease

Belgium, Netherlands, Finland
Imelda GI Clinical Research Center

Completed

pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis (APOLLO)

Ulcerative Colitis

Belgium
KU Leuven

Completed

Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis

Ulcerative Colitis

Belgium
Abivax S.A.

Completed

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
University of Liege; University Hospital, Ghent; Imelda Hospital, Bonheiden; AZ... and other collaborators

Completed

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis (CEDAR UC)

Ulcerative Colitis

Belgium
Abivax S.A.
Orion Corporation, Orion Pharma

Active, not recruiting

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Toray Industries, Inc

Completed

A Study of TRK-170 for the Treatment of Crohn's Disease

Crohn's Disease

Bulgaria, France, Hungary, Belgium, Czech Republic, Latvia, Netherlands, Norway, Poland, Romania, Serbia, Sweden, Ukraine
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (CONNECT-IBD)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis

France, Spain, United Kingdom, Czechia, Italy, Belgium, Germany, Netherlands, Greece, Finland, Hungary, Portugal, Slovakia
Facet Biotech

Completed

Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis

Ulcerative Colitis | Inflammatory Bowel Disease | Gastrointestinal Disease

United States, Canada, Belgium
Shire

Completed

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy (CAPSCDEIS)

Crohn's Disease

France, Belgium
Universitaire Ziekenhuizen KU Leuven
Imelda GI Clinical Research Center; Sapporo Medical University

Unknown

PRognOstiC valuE of rEd Density in Ulcerative Colitis (PROCEED-UC)

Ulcerative Colitis

Belgium
Boehringer Ingelheim

Completed

A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease

Crohn Disease

Belgium, Germany, Austria, Korea, Republic of, Netherlands, Denmark, Hungary, Spain
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Unknown

Golimumab Dried Blood Spot Analysis (GOUDA)

Ulcerative Colitis

Belgium
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

Intestinal Fistula | Inflammatory Bowel Disease

United States, Israel, Canada, United Kingdom, Germany, Belgium, Hungary, France, Austria, Czech Republic, Netherlands, Poland
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium

Unknown

Restoration of the Microbiome Through Superdonor Selection (RESTORE-UC)

Ulcerative Colitis

Belgium
Geert D'Haens
Takeda

Completed

A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOVE-CD)

Crohn Disease

Belgium, Netherlands, Hungary

Clinical Trials on Inflammatory Bowel Diseases in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations